Genetically engineered islets and alternative sources of insulin-producing cells for treating autoimmune diabetes: quo vadis?

about

Rodent models for investigating the dysregulation of immune responses in type 1 diabetes.Reprogramming mouse embryo fibroblasts to functional islets without genetic manipulation.

P2860

Q36825707-CDEAC51B-867A-4B9C-AAD5-A9528612C4E3 Q38705454-B70841D4-2046-4AF8-AF26-E8E093D98DA5

P2860

Genetically engineered islets and alternative sources of insulin-producing cells for treating autoimmune diabetes: quo vadis?

Item

http://www.wikidata.org/entity/Q36011576

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Genetically engineered islets ...... utoimmune diabetes: quo vadis?

@ast

Genetically engineered islets ...... utoimmune diabetes: quo vadis?

@en

type

Item

label

Genetically engineered islets ...... utoimmune diabetes: quo vadis?

@ast

Genetically engineered islets ...... utoimmune diabetes: quo vadis?

@en

prefLabel

Genetically engineered islets ...... utoimmune diabetes: quo vadis?

@ast

Genetically engineered islets ...... utoimmune diabetes: quo vadis?

@en

P1476

Genetically engineered islets ...... utoimmune diabetes: quo vadis?

@en

P2093

Huey-Kang Sytwu

http://www.w3.org/2001/XMLSchema#string

Shing-Hwa Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

Epigenetic memory in induced pluripotent stem cells

Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo

Immunogenicity of induced pluripotent stem cells

Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes.

TLR signals promote IL-6/IL-17-dependent transplant rejection.

Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells.

P304

296485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/296485

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P50

Feng-Cheng Chou

P577

2012-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225294011

http://www.w3.org/2001/XMLSchema#string

P698

22690214

http://www.w3.org/2001/XMLSchema#string

P932

3368364

http://www.w3.org/2001/XMLSchema#string

Genetically engineered islets and alternative sources of insulin-producing cells for treating autoimmune diabetes: quo vadis?

about

P2860

P2860

Genetically engineered islets and alternative sources of insulin-producing cells for treating autoimmune diabetes: quo vadis?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932